Researchers in cardiovascular medicine, rheumatology, inflammation and other disciplines must now take up the challenge and identify what it is about hyperuricemia and gout that impacts on ...

VOC暴露与全身炎症水平增加有关，然而尿液VOC代谢物与全身性炎症之间的剂量-反应关系尚未建立，其中有毒化合物的关键代谢物也处于未知的状态。PAEs是一类广泛而复杂的人造芳香族化合物，被广泛应用于塑料制品、溶剂、润滑剂和粘合剂中，其代谢物导致血清尿酸 ...

Hyperuricemia (HU), characterized by elevated uric acid (UA) levels in the blood, is a global health concern associated with various conditions, including cardiovascular diseases, gout, hypertension, ...

For many people, pain at the beginning of a gout attack (typically the first 24 hours) tends to be the worst. There are a ...

Gout causes extremely painful episodes of acute inflammatory arthritis ... even though their exact relationship with hyperuricemia and gout is currently uncertain. These comorbidities need ...

Gout is a type of inflammatory arthritis that affects over 9 million American adults. It results from hyperuricemia (high ...

The metabolic syndrome is a cluster of cardiovascular risk factors that are of metabolic origin and include atherogenic dyslipidemia, hypertension and hyperglycemia. This syndrome is generally ...

Uric acid is created by the body when it breaks down substances known as purines. If your body produces too much uric acid, ...

ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal ...

Ltd (Atom Therapeutics), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and ... treatment of chronic gout and hyperuricemia, in mainland China, Hong ...